PALO ALTO, Calif., Jan. 8, 2025 — Qualified Health today announced its launch with $30 million in seed funding to develop the infrastructure for generative AI in healthcare. The major investors are SignalFire, Healthier Capital, Town Hall Ventures, and Frist Cressey Ventures, along with participation from Intermountain Ventures, Flare Capital Partners, and prominent healthcare and technology sector angels.

“Healthcare stands at a pivotal moment, our providers are overwhelmed, our costs are increasing, and we must make a change,” said Justin Norden, MD, Co-Founder and CEO of Qualified Health. “This strong backing from leading healthcare-technology investors and health systems validates our approach to bridging the gap between Generative AI’s potential and healthcare’s need for reliability, transparency, and safety.”

The company’s technology solution provides healthcare organizations with comprehensive infrastructure to implement and scale generative AI solutions safely. Key features include:

• Enforceable Governance: Role-based access controls, risk alerts, data privacy protections, and safeguards against AI hallucinations
• Healthcare Agent Creation: Infrastructure enabling healthcare teams to rapidly develop and deploy AI agents for workflow automation
• Post-Deployment Monitoring: Complete observability of application performance and usage, with human-in-the-loop evaluation and escalation systems

“While other industries have seen transformative benefits from generative AI, healthcare adoption has been cautious due to justified concerns about safety and reliability,” said Qualified Health board member Sooah Cho from SignalFire. “Qualified Health’s infrastructure creates the foundation of trust necessary for healthcare organizations to confidently deploy these powerful tools.”

“What sets Qualified Health apart is their unique approach to healthcare AI governance,” said Navid Farzad of Frist Cressey Ventures. “Their platform enables health systems to maintain control while accelerating innovation – a crucial balance that the industry has been seeking.”

The company brings together an experienced founding team with backgrounds spanning healthcare delivery, AI development, and quality improvement:

• Justin Norden, MD, MBA (CEO/Co-founder): Stanford Medicine faculty member and former CEO/Co-founder of Trustworthy AI (acquired by Waymo/Google)
• Shantanu Phatakwala: (CCO/Co-founder): Former Chief Data Science Officer at Haven (Amazon/JP Morgan Chase/Berkshire Hathaway venture)
• Beau Norgeot, PhD (CAIO/Co-founder): Former VP of AI at Elevance and Chief AI Officer at Lucid Lane
• Nirav R. Shah, MD, MPH (Co-founder): Stanford Medicine faculty member and Former COO of Kaiser Permanente SoCal and NY State Health Commissioner
• Kedar Mate, MD (CMO/Co-founder): Former President and CEO of the Institute for Healthcare Improvement (IHI)

Notable angel investors include Frank Williams (former CEO/Founder of Evolent), Justin Kan (former CEO/Founder of Twitch), Bill Veghte (former EVP Microsoft, EVP Hewlett Packard), Varsha Rao (former CEO of Nurx), and more.

“The caliber of talent Qualified Health has assembled is extraordinary,” noted Meera Mani, MD from Town Hall Ventures. “This team brings together decades of healthcare transformation experience with deep technical expertise in AI – exactly what’s needed to solve one of healthcare’s most complex challenges.”

“We’re at the beginning of a fundamental shift in how healthcare is delivered,” added Amir Dan Rubin from Healthier Capital. “Qualified Health is uniquely positioned to become the cornerstone that enables safe, effective AI deployment across the entire healthcare ecosystem. The opportunity ahead is immense.”

About Qualified Health:

Qualified Health is a public benefit corporation providing the infrastructure for generative AI in healthcare. Through its comprehensive platform, deep healthcare expertise, and commitment to provider partnerships, Qualified Health enables healthcare organizations to unlock the value of generative AI responsibly. For more information, visit www.qualifiedhealthai.com.

CONTACT: [email protected]

SOURCE Qualified Health PBC

IRVINE, Calif., Jan. 8, 2025 — Relief Cardiovascular, an inQB8 Medical Technologies portfolio company pioneering innovative solutions for the management of heart failure, today announced the closing of a $12M Series A financing. The funding round was co-led by Broadview Ventures and Advent Life Sciences, with participation from Pacific Health Investment, Heartwork Capital, and an undisclosed multinational strategic. The funds will support further product development and the initiation of the company’s first-in-human feasibility study, designed to evaluate the safety and efficacy of the Relief System – a transcatheter smart implant designed to monitor and modulate renal vein pressures, offering a novel approach to fluid management in heart failure.

As part of the financing, Shahzad Malik, MD, General Partner at Advent Life Sciences, and Maria Berkman, MD, Head of Medtech at Broadview Ventures, will join the company’s Board of Directors.

“Heart failure continues to impose a tremendous burden on patients and healthcare systems,” said Maria Berkman, MD. “The Relief System addresses a critical gap in patient care, and we are proud to partner with the team at Relief Cardiovascular to advance this novel therapy into the clinic.”

“Relief Cardiovascular’s innovative approach to volume management tackles the unmet needs of diuretic-resistant heart failure,” said Shahzad Malik, MD. “The Relief System’s ability to dynamically modulate renal vein pressures offers the potential to redefine treatment and improve outcomes for patients facing limited options.”

The Relief System employs a transcatheter implant to reduce renal vein pressure using an innovative “puller” mechanism, paired with integrated sensors that autonomously capture renal vein pressures and multiparametric data. The system provides physicians with actionable data for optimizing fluid management and offers tailored therapeutic device-driven intervention.

“The Relief System’s ability to integrate monitoring and therapeutic modulation of renal pressures represents a promising advance in volume management in heart failure,” said William T. Abraham, MD, Professor of Medicine at The Ohio State University Wexner Medical Center. Alex Rothman, MD, Professor of Cardiology at the University of Sheffield, added, “By enabling data-driven adjustments, the Relief System empowers more personalized and effective care for patients, particularly those with diuretic resistance.”

“This financing marks a pivotal milestone for us as we advance the Relief System into human clinical studies,” said Alex Cooper, CEO of Relief Cardiovascular. “We’re honored to have the support of world-class investors and clinicians, along with industry veterans like Michael Minogue. With Shahzad and Maria joining our board, our team is positioned to transform the management and treatment of heart failure.”

About Relief Cardiovascular
Relief Cardiovascular is a privately held medical device company committed to improving outcomes for patients with heart failure. The company’s flagship technology, the Relief System, is a transcatheter smart implant designed to enhance fluid management and improve quality of life for heart failure patients. Relief Cardiovascular was founded and incubated within inQB8 Medical Technologies, LLC.

About Broadview Ventures
Broadview Ventures is a mission-driven investment organization that makes targeted investments in early-stage companies to accelerate the development of innovative therapeutics, devices, and diagnostics for cardiovascular disease and stroke. Broadview is funded by the Leducq Charitable Trust. For more information, please visit www.broadviewventures.org

About Advent Life Sciences
Advent Life Sciences founds and invests in early- and mid-stage life sciences companies that have a first- or best-in-class approach to unmet medical needs. The investing team consists of experienced professionals, each with extensive scientific, medical and operational experience, a long-standing record of entrepreneurial and investment success in the US and Europe and is particularly focused on supporting entrepreneurs and founders to take innovative new medical entities from concept to approval. The firm invests in a range of sectors within life sciences, principally drug discovery, enabling technologies and med tech, always with an emphasis on innovative, paradigm-changing approaches. Advent Life Sciences has a presence in the UK, US and France. For more information, please visit www.Adventls.com

About inQB8 Medical Technologies

inQB8 Medical Technologies is a privately held medical device incubator based in Massachusetts, co-founded by Dr. Arshad Quadri, MD, and J. Brent Ratz, MBA. inQB8 specializes in developing cutting-edge interventional solutions for major cardiovascular diseases, accelerating projects through prototyping, bench, and pre-clinical testing.

For inquiries, contact: [email protected]

SOURCE Relief Cardiovascular

The firm’s fifth fund focuses on taking advantage of the unprecedented growth in sports and entertainment worldwide

SAN FRANCISCO, Jan. 8, 2025 — Scrum Ventures, a San Francisco and Tokyo-based early-stage venture capital firm, today announced the closing of its first vertically focused tech fund, Scrum Sports & Entertainment Fund I (SSE). The new fund, which closed at $68 million, invests in technology companies that support the growth of the sports and entertainment sector but also transcend the vertical and address market inefficiencies in other industries.

SSE’s investment strategy centers around several key megatrends that are shaping the future of sports and entertainment:

• Unprecedented Growth: The sports and entertainment industries are experiencing remarkable expansion worldwide, presenting unparalleled opportunities for innovative startups. PwC noted the global market is projected to reach $680 billion by 2028.
• Globalization of Sports: Sports are transcending geographical boundaries, creating a truly global market with immense potential for companies capable of catering to a diverse and interconnected audience.

“The sports and entertainment sectors are experiencing explosive global growth, and we see tremendous potential for technological innovation to disrupt and enhance these industries, said Tak Miyata, founder and general partner of Scrum Ventures. “Japan, in particular, is a market ripe with opportunity, and we’re uniquely positioned to leverage our deep connections and expertise to help our portfolio companies expand.”

SSE has already established a strong foothold in the sports and entertainment sectors, having made strategic investments in 16 promising companies, including;

• Fever:  a live-entertainment discovery tech platform aiming to make culture and entertainment more accessible.
• TMRW Sports: an operator of a sports media and technology platform intended to bring golf and other related sports services to customers.
• Campus Ink: a merchandising platform designed specifically for students and athletes.
• Ozlo Sleep: a science-driven sleep and audio technology company that simplifies sleep rituals without the use of medication.
• Bandit Running: a retail apparel company offering sports and athleisure apparel for men and women.
• Volo Sports:  a social and recreational sports organization offering access to a range of activities, and virtual events for young adults.
• Misapplied Sciences: a developer of a parallel reality technology that allows viewers to share a digital display and see something different

These early investments underscore Scrum Ventures’ commitment to identifying and supporting future leaders in these dynamic industries.

The fund is run by two seasoned industry veterans Kazuhiro Kiyoshige and Michael Proman. Kiyoshige brings over two decades of experience in the sports and entertainment sectors, having honed his skills at Dentsu, where he specialized in international sports marketing and broadcasting rights. Proman complements Kiyoshige’s expertise with his extensive background in global marketing and development, having held key positions at Coca-Cola and the National Basketball Association before founding and successfully exiting his own startup, OptionIt.

The new fund’s limited partners include prominent Japanese corporations, including SBI Group, Oriental Land Innovations Co., Ltd., QR Investment Co., Ltd. Hokkoku Financial Holdings Group), KOEI TECMO  Group JAPANET HOLDINGS Co., Ltd., Sumitomo Corporation of Americas, SEGA SAMMY HOLDINGS INC., TV Asahi Holdings Corporation, TOHO Global Inc., Nippon Television Holdings, Inc., HISA KINZOKU KOGYO., LTD, Sumitomo Mitsui Trust Bank, Limited, MUFG Bank, Ltd., WOWOW Inc. as well as other business companies, financial institutions, individual investors, etc.

About Scrum Ventures
Founded in 2013, Scrum Ventures has been helping launch and grow innovative startups with an eye toward expanding into Japan and beyond. Its unique venture model serves as an innovation gateway between the United States and Japan, helping to connect founders to the world’s most iconic brands, customers, and technologies to expedite growth and create category-leading businesses.

Contact:
Mary Magnani
CodePR
[email protected]

SOURCE Scrum Ventures

HARLINGEN, Texas, Jan. 8, 2025 — Frontier Direct Care, a leading innovator in employer-funded healthcare, has announced the initial closing of its $20 million Series B funding round, led by Mehshah Capital. This investment will accelerate the company’s mission to transform healthcare by delivering accessible, affordable, and high-quality care to employees and their families.

Frontier Direct Care offers a comprehensive suite of solutions designed to improve health outcomes while reducing costs. The company’s services include direct primary care, virtual care, referral navigation / direct contracting, and a prescription plan – all integrated through a proprietary technology platform. By removing traditional barriers such as co-pays, deductibles, and administrative complexities, Frontier enhances access to care and reduces downstream expenses. Key strategies include:

• Producing significant savings on healthcare spend and passing them directly to employers.
• Delivering care in the most appropriate settings.
• Reducing unnecessary healthcare utilization.
• Negotiating direct cash-pay rates with providers.

Over the past two years, the company has expanded its membership base by over 10x and now serves more than 100 employer customers, including municipalities, school districts and private employers, all of whom face rising healthcare costs. In the first half of 2025, Frontier plans to open new clinics in Dallas, Austin, and Houston.

“At Frontier Direct Care, we are reimagining how healthcare is delivered and paid for,” said Bibb Beale, CEO of Frontier Direct Care. “This funding, led by Mehshah Capital, enables us to expand our footprint, enhance services, and continue delivering exceptional care to our growing membership.”

Mehshah Capital’s investment in Frontier reflects its strategy of investing in and supporting transformative healthcare companies positioned at the intersection of change. 

“The current employer-funded healthcare system is unsustainable. Frontier Direct Care is disrupting this status quo with an innovative model that improves access, elevates quality of care, and lowers costs. We’re excited to support Frontier in its next phase of growth,” said Gaurav Mehta, Managing Partner at Mehshah Capital. 

As part of the Series B round, Frontier welcomes three new board members: Richard Barasch, former Chairman and CEO of Universal American Corporation and Founder of RAB Ventures; Eric Bricker, M.D., Co-Founder of Compass Professional Health Services, and Gaurav Mehta, Founder and Managing Partner of Mehshah Capital.

About Frontier Direct Care 

Frontier Direct Care is transforming employer-sponsored healthcare by offering an integrated, technology-enabled platform that combines direct primary care, virtual care, referral navigation / direct contracting, and a prescription plan to improve quality of care and reduce costs. For more information, visit frontierdirectcare.com.

About Mehshah Capital 

Mehshah Capital is a New York City-based private equity firm known for its high-touch, value-add approach. The firm focuses on investing in transformative healthcare companies, with a proven value proposition, poised to drive meaningful change. For more information, visit mehshah.com.

Media Contact: Brad Springer | [email protected] | (956) 983-9272

SOURCE Frontier Direct Care

AI Leader in Enterprise Refrigeration Management Adds Top 10 Grocery Retailer as Existing Investors Expand their Positions

SAN JOSE, Calif., Jan. 8, 2025 — Axiom Cloud, a leader in AI-powered refrigeration management solutions, has announced a new contract with a Top 10 U.S. grocery retailer, and the successful close of a new funding round led by existing investors Blue Bear Capital, Leadout Capital and Vela Partners. The funding will enable Axiom to scale operations to meet rapidly growing market demand for solutions that reduce operational costs, improve energy efficiency and advance sustainability goals.

“We’re seeing a tidal wave of demand from retailers and cold storage operators who recognize that modernizing refrigeration management delivers immediate bottom-line impact and makes their lives easier in the first month,” said Amrit Robbins, CEO and Co-Founder of Axiom Cloud. “This significant new grocery retail contract, coupled with a large number of active customer pilots, shows that the tide is turning – the market transition to software-only refrigeration management is accelerating fast.”

By integrating with existing control systems, Axiom’s solution enables fully-remote deployments at 100+ sites per week without requiring any new hardware or onsite visits. Axiom helps its retail grocery and cold storage customers build customized, data-driven business cases for its Early Leak Detection, Predictive Maintenance, and Energy Efficiency modules. Enterprise deployments typically deliver a three times return on subscription fees or higher. 

“Since leading Axiom’s Series A round in 2022, we’ve watched the company establish itself as the clear market leader in AI-powered refrigeration management,” said Ernst Sack, Board Director at Axiom Cloud and Founding Partner at Blue Bear Capital. “With this latest enterprise win and additional capital, Axiom is uniquely positioned to help the $1.7 trillion cold chain sector dramatically reduce costs and environmental impact while improving operational reliability.”

The company’s Early Leak Detection (ELD) module has demonstrated best-in-class performance across hundreds of facilities, leveraging AI to optimize refrigeration system performance, reduce operating costs, slash greenhouse gas emissions, and enable regulatory compliance with state and federal laws. The solution is recognized by both the EPA and the California Air Resources Board (CARB) as a compliant indirect leak detection system, helping customers stay ahead of evolving regulatory requirements while focusing on core business objectives.

About Axiom Cloud: Axiom Cloud uses AI and automation to transform how the world’s cooling systems are powered, operated, and maintained, in order to generate significant climate and financial impact. Axiom’s team of refrigeration experts, data scientists, energy nerds, and software developers solves the cold chain’s biggest energy and maintenance challenges by providing the digital layer for their existing refrigeration systems. axiomcloud.ai

About Blue Bear Capital: Blue Bear is a venture capital and early growth equity firm driving digital technologies and machine intelligence into multibillion-dollar verticals across the energy, infrastructure, and climate industries. The team comes from leading energy private equity firms, startups, and large industrial technology developers. Blue Bear typically leads Seed through Series B rounds, with a portfolio covering operational AI, IoT, and cybersecurity technologies, all deployed with enterprise customers to drive connectivity and intelligence across the world’s most critical industries. More information can be found at bluebearcap.com.

Contact:
Emily Torrans
Mahoney Communications Group
[email protected]
212-220-6678

SOURCE Axiom Cloud

NEW YORK, Jan. 8, 2025 — Deep Vector, an AI platform for analyzing underwriting documents, closed its seed round of $1.5M, co-led by Aperture Venture Capital and InsurTech NY.

Deep Vector helps insurers and brokers translate the influx of analog documents used for underwriting risk—claims loss runs, Acord forms, motor vehicle records, and business records—into usable and actionable data. Previously known as Loss Scan, Deep Vector uses a proprietary algorithm and machine learning to classify documents from a library of 5,600+ formats specific to each insurance carrier’s forms. Once identified, Deep Vector processes and translates the documents into usable data for carriers, brokers, and risk managers.

“Insurers have little incentive to make their loss run and claims analysis process easier because it is simply a cost center,” said David Gritz, Managing Director at InsurTech NY. “Deep Vector bridges the gap between the insurance broker and underwriter for complex commercial accounts and saves thousands of hours analyzing accounts.”

Deep Vector seeks to become the default translation layer for insurance data extraction. Over 30 of the top 100 insurance brokerages and many more carriers, underwriters, MGAs, and brokers have already transformed their operations with Loss Scan. The rapid adoption by industry leaders shows that Deep Vector isn’t just innovative – it’s delivering real results for the most demanding organizations in insurance.

“We are excited about the growth prospects for Deep Vector,” said Garnet Heraman, General Partner at Aperture VC. “The insurance industry is the largest data repository for business. Deep Vector unlocks that data for better risk modeling, resource management, and ultimately better customer experiences.”

Founders Scott Knowles and Wesley Janse van Rensburg understand the market. Knowles started his career as a commercial insurance broker, and most recently, the team sold their insurance analytics business, Modgic, to Zywave.

“Deep Vector’s product Loss Scan breaks down the barriers that have locked away valuable claims data for decades. By automating the extraction of information from complex loss runs, we’re giving insurance professionals access to previously buried insights in PDFs and spreadsheets. It’s not just about saving time – it’s about unlocking data that transforms how underwriters assess risk and brokers serve their clients.” said Scott Knowles, co-founder of Deep Vector. “Only with the power of Deep Vector can brokers shift their time to true risk management and advisory instead of paperwork processing. By automating the tedious task of manual data extraction, we’re liberating insurance professionals to focus on what matters – analyzing risks and providing strategic guidance to their clients.”

The Deep Vector will showcase its breakthrough technology next at the InsurTech Spring Conference on April 2-3 at Pier 60 in NYC.

About Deep Vector

Deep Vector extracts data with unparalleled accuracy in seconds from complex documents. The company stated in insurance processing Loss Runs and is now multi-sector. The platform’s engine adapt to any document type or industry. This approach supports data processing in finance, healthcare, and government sectors. More information at www.deepvector.com

About Aperture Venture Capital

Aperture is a seed-stage investor in startups leveraging financial innovation and AI. Its first fund was launched in 2021 with investments from global financial technology giants FIS, Truist, PayPal, Bank of America, Progressive, MassMutual, as well as NextEra Energy. Aperture’s fund platform is purpose-built to invest with expertise across the full spectrum of financial services including banking, payments, insurance, security, compliance and enterprise SaaS. Learn more at https://aperturevc.com/.

About InsurTech NY

InsurTech NY is an international nexus for the insurance innovation community, bringing together insurers, investors, and InsurTechs through conferences, competitions, and accelerators. The organization accelerates corporate innovation, attracts talent to the insurance sector, fosters innovation-friendly regulations, and enhances access to investment opportunities. More information at insurtechny.com.

Media Contact:
David Gritz
212-634-9516
[email protected]

SOURCE InsurTech NY

DALLAS, Jan. 8, 2025 — Winning high-value projects on Upwork isn’t just about putting in the time; it’s about standing out in a crowd of equally talented freelancers. That’s why PouncerAI, a VC-backed startup co-founded by former freelancers Sean Jackson and Daniel Reiling, has developed an AI-powered Chrome Extension to give freelancers a competitive edge in crafting winning proposals—while also saving hours each week.

Leveling the Playing Field in a Growing Market

With more than 163 million freelancers worldwide (NIH) and the U.S. market projected to expand from 76 million in 2024 to 90 million by 2028, competition on platforms like Upwork has never been fiercer. And for successful freelancers aiming to increase their annual earnings—rather than just get by—every advantage counts.

“As freelancers ourselves, my co-founder and I felt the frustration of missing out on gigs simply because someone else had a more compelling pitch—or beat us to it,” says Sean Jackson, CEO of PouncerAI. “We built PouncerAI to help freelancers not only apply faster but also stand out with professional, high-conversion proposals.”

The “Be First” Advantage

• Instant Job Alerts:
  PouncerAI’s extension scans Upwork job postings in real time, notifying freelancers of new opportunities the moment they appear. This means you can apply in under 30 seconds, increasing your chances of being noticed—and hired—by clients reviewing early submissions.
• Time Saved, More Projects Won:
  Most experienced freelancers spend 20 minutes researching and writing each proposal, adding up to 3–6 hours per week of unpaid work. With PouncerAI, the application process is reduced to seconds, freeing you up to bid on more projects or invest extra time in client-facing tasks that generate revenue.

High-Converting Proposals Made Easy

Building on direct response copywriting frameworks, PouncerAI’s proposal templates are designed to convert. Unlike generic AI writing tools that can produce long-winded or robotic text, PouncerAI ensures your proposals are clear, concise, and immediately relevant to a client’s needs. This isn’t just an efficiency play; it’s about landing the project.

• Optimized for Conversion:
  Proposals follow proven, persuasive structures that grab a client’s attention.
• No AI “Giveaway” Tone:
  Say goodbye to obviously AI-generated phrasing—PouncerAI’s templates sound human and professional.
• 95% Coverage:
  With a comprehensive library of templates, freelancers can apply to the vast majority of Upwork jobs quickly and effectively.

Success Stories from Seasoned Freelancers

Even for top-performing freelancers, the simple act of bidding can be a hurdle:

“Our profile on Upwork has more than 400K+ in earnings and over 4,200 hours clocked, but the bidding process was always hit-or-miss,” says Sajal Gupta, a WordPress developer. “The ease this tool brings to the process is unparalleled.”

Pricing & Availability

• Free 14-Day Trial: Explore PouncerAI’s features at no cost.
• Flexible Plans: Choose from three subscription tiers, starting at $16/month.
• Worldwide Release: Download the updated Chrome Extension immediately via the Google Chrome Store.

About PouncerAI

Founded in 2024 by Sean Jackson and Daniel Reiling, PouncerAI Inc. is a Dallas-based, venture-backed startup committed to helping freelancers get more work fast. Leveraging AI and hands-on experience from their own days as freelancers, the co-founders built a tool that not only saves time but also boosts the quality—and success rate—of proposals.

Ready to reduce your bidding time and stand out in a crowded marketplace? Visit https://pouncer.ai to learn more and sign up for a free 14-day trial.

PouncerAI is not affiliated with or endorsed by Upwork Inc. or any of its subsidiaries.

Media Contact
Sean Jackson | PouncerAI Inc.
(214) 675-1100
[email protected] 
Dallas, TX

SOURCE PouncerAI Inc.

SANTA CLARA, Calif., Jan. 8, 2025 — Zeto, Inc., a fast-growing medical technology company revolutionizing EEG diagnostics with its cutting-edge devices and AI-driven cloud platform, has announced the recent successful closing of a $31 million funding round.

The funding round was led by MindWorks Global (MWG), a Michigan-based investment entity funded by visionary entrepreneur-investors with a track record of building multi-billion-dollar enterprises. MWG’s Founder, CEO and Lead Partner, Mike Williams, is an accomplished entrepreneur and investor known for his expertise in scaling companies across different industries, including achieving a $1.1 billion exit from his most recent venture. Mike Williams said, “Zeto’s vision and technology are truly transformative for the medical arena and beyond, and we are excited to leverage our expertise and network to help drive the company’s growth. The world of EEG is going to be transformed immensely in the upcoming years, and Zeto is going to be at the forefront of it. Brain health assessment will extend beyond traditional healthcare, and we’re excited to support Zeto in pioneering new frontiers. It’s an exciting day!”

Aswin Gunasekar, Zeto’s Founder and CEO said, “Zeto has reached a pivotal milestone, earning a reputation for game-changing innovation and experiencing rapid adoption of our solutions by leading healthcare institutions across the U.S. Our management team has long aspired to collaborate with accomplished entrepreneur-investors who have successfully scaled companies to drive meaningful societal impact and significant revenue. We are excited to welcome MindWorks Global partners to our board of directors who bring not only capital but also invaluable expertise, extensive experience, and a powerful network. Our dedicated team is eager to embark on this exciting next chapter in our company’s journey.”

Zeto is grateful for the steadfast support and continued investments from its prior investors over the years. This new funding will enable Zeto to expand its commercial and operational teams, drive further growth and strengthen ongoing research and development efforts.

About Zeto, Inc.

Zeto, Inc., an award-winning medical technology company, is at the forefront of advancing EEG brain monitoring and diagnostics in healthcare. Through its innovative wearable devices, Zeto makes brain monitoring accessible in diverse clinical settings, including the ICU, ED, hospitals, offices, and at home. Backed by a powerful cloud-based platform, Zeto delivers nationwide monitoring and interpretation services by neurologists, along with AI-driven notifications for conditions such as seizures and epilepsy. Looking ahead, Zeto plans to expand its capabilities to detect and manage conditions like depression, stroke and traumatic brain injury. Zeto’s EEG systems, which received FDA clearances in 2018 and 2024, are currently commercially available in the United States.

To learn more about Zeto’s products, please visit: https://zeto-inc.com or email us at [email protected].

SOURCE Zeto, Inc.

DES MOINES, Iowa, Jan. 8, 2025 — Red Rover Health, which enables healthcare providers to integrate “best of breed” third-party solutions into their electronic health record (EHR) systems, has received $4 million in seed funding from NewShore Partners. The latest funding gives Red Rover the capital to hire key talent to expand the core integration platform and scale operations.

“This funding makes sense for us right now for a couple of reasons,” said Red Rover CEO John Orosco. “First, we have an active working solution deployed in numerous production sites, so this isn’t vaporware or an idea on paper. Second, we must take advantage of current momentum in terms of contractual commitments from vendor partners and enterprise deals forthcoming. This capital will help us scale operations, accelerate sales and marketing, and hire more industry rockstars.”

The emergence of world class “best of breed” third-party software solutions, or apps, has driven the need for EHR integration for healthcare providers. Clinicians are demanding real-time access to patient care information but existing integration solutions like HL7 and FHIR do not always meet bi-directional integration needs.

Red Rover’s healthcare integration platform leverages RESTful APIs to seamlessly integrate third-party software apps with designated EHRs. The platform offers “best of breed” software solutions secure and predictable access to health system EHR data. This provides healthcare organizations access to world-class solutions to make the most of their EHR investment.

In addition to providing capital, NewShore Partners intends to act as a strategic partner to Red Rover. “We invest in innovative companies that are bold enough to build solutions for the biggest challenges in healthcare,” said NewShore Director Sowri Krishnan. “Red Rover Health’s platform makes ‘best of breed’ apps available to clinicians without health systems undergoing expensive and resource-draining integration projects that hinder innovation. The end result will be better patient outcomes and reduced costs for hospitals and health systems.”

About Red Rover Health
Red Rover Health, Inc., headquartered in Des Moines, Iowa, is a pioneering healthcare technology company dedicated to simplifying Electronic Health Record (EHR) integration. Powered by secure RESTful APIs, Red Rover’s integration platform enables seamless connectivity between third-party software applications and EHR systems. This innovative platform empowers healthcare organizations to enhance their existing EHR systems with world-class, best-of-breed software solutions. To learn more, visit www.redrover.health.

About NewShore Partners
NewShore Partners is a forward-thinking company dedicated to investing in innovative technology companies. NewShore looks to incubate groundbreaking ideas and help transform them into impactful solutions. NewShore’s focus is on empowering early-stage management teams, helping them scale their businesses, and turning ambitious visions into reality.

Media Contact:
Yancey Casey
Amendola Communications for Red Rover Health
(678) 895-9401
[email protected]

SOURCE Red Rover Health